Cerubidine and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cerubidine (daunorubicin hydrochloride) and Lantus (insulin glargine recombinant). Common drug interactions include alopecia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Cerubidine and Lantus. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Cerubidine?

Cerubidine has active ingredients of daunorubicin hydrochloride. eHealthMe is studying from 637 Cerubidine users. Check the latest studies of Cerubidine.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Jul, 13, 2026

16 people who take Cerubidine and Lantus together, and have interactions are studied.

Cerubidine and Lantus drug interactions.

What are the common drug interactions of Cerubidine and Lantus, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Hair colour changes
Hair disorder
Emotional distress
Psychological trauma

male:

Anaemia (lack of blood)
Leukopenia (less number of white blood cells in blood)
Hallucination (an experience involving the perception of something not present)
Renal failure (kidney dysfunction)
Septic shock (shock due to blood infection)
Catheter related infection
Cardiac failure
Device related infection
Ejection fraction decreased (systolic heart failure)
Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Cerubidine and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Alopecia (absence of hair from areas of the body)
Emotional distress
Psychological trauma
Hair colour changes
Hair disorder

50-59:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Diabetes mellitus inadequate control
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Vanishing bile duct syndrome (loose collection of diseases which leads to the injury to hepatic bile ducts and eventual ductopenia)
Alopecia (absence of hair from areas of the body)
Hair colour changes
Hair disorder
Cardiac failure
Ejection fraction decreased (systolic heart failure)

60+:

Candida sepsis (candida in blood stream)
Hallucination (an experience involving the perception of something not present)
Renal failure (kidney dysfunction)
Septic shock (shock due to blood infection)
Catheter related infection
Device related infection

What are the existing conditions these people have? *

Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 5 people, 31.25%
Insomnia (sleeplessness): 3 people, 18.75%
High Blood Pressure: 3 people, 18.75%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 18.75%
Breast Cancer Female: 2 people, 12.50%
Infection: 1 person, 6.25%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Cerubidine and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously